All Stories

  1. Anti-Neu5Gc Antibodies do not Affect Response to Human or Chimeric Monoclonal Anti-CD20 Antibodies in Children with Nephrotic Syndrome
  2. Reply to: “On the Importance of Considering Glycosylation when Evaluating Biologics”
  3. Second Wave Antibodies in Autoimmune Renal Diseases: The Case of Lupus Nephritis
  4. Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial
  5. Vaccines and Disease Relapses in Children with Nephrotic Syndrome
  6. Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy
  7. COVID-19 in immunodpressed children
  8. Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes
  9. Publisher Correction: Biological surface properties in extracellular vesicles and their effect on cargo proteins
  10. An Update on Antibodies to Necleosome Components as Biomarkers of Sistemic Lupus Erythematosus and of Lupus Flares
  11. Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease
  12. Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
  13. Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome
  14. Biological surface properties in extracellular vesicles and their effect on cargo proteins
  15. Neutrophil extracellular traps (NET) induced by different stimuli: A comparative proteomic analysis
  16. Neutrophil Extracellular Traps protein composition is specific for patients with Lupus nephritis and includes methyl-oxidized αenolase (methionine sulfoxide 93)
  17. Health-related quality of life in glomerular disease
  18. High-Content Screening Identifies Vanilloids as a Novel Class of Inhibitors of NET Formation
  19. Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease
  20. Surgical validation of functional magnetic resonance urography in the study of ureteropelvic junction obstruction in a pediatric cohort
  21. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy
  22. Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  23. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
  24. The copy number variation landscape of congenital anomalies of the kidney and urinary tract
  25. Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study
  26. Microvesicles as promising biological tools for diagnosis and therapy
  27. Drug-induced lupus: Traditional and new concepts
  28. Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study
  29. Exploring the Clinical and Genetic Spectrum of Steroid Resistant Nephrotic Syndrome: The PodoNet Registry
  30. Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease
  31. Annexin A1 and Autoimmunity: From Basic Science to Clinical Applications
  32. Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome
  33. Hydronephrosis and crossing vessels in children: Optimization of diagnostic-therapeutic pathway and analysis of color Doppler ultrasound and magnetic resonance urography diagnostic accuracy
  34. Proteome of Bovine Mitochondria and Rod Outer Segment Disks: Commonalities and Differences
  35. Genetic basis of human congenital anomalies of the kidney and urinary tract
  36. FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome
  37. Metabolic Signature of Microvesicles from Umbilical Cord Mesenchymal Stem Cells of Preterm and Term Infants
  38. Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations
  39. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS
  40. Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations
  41. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases
  42. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex–Mediated Membranoproliferative GN
  43. Further phenotypic heterogeneity of CoQ10 deficiency associated with steroid resistant nephrotic syndrome and novel COQ2 and COQ6 variants
  44. Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
  45. Genetic Drivers of Kidney Defects in the DiGeorge Syndrome
  46. Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease
  47. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients
  48. Clinical trials in minimal change disease
  49. Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory–autoimmunity connection
  50. Ofatumumab-associated acute pneumonitis: Not new but still the first case
  51. Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab
  52. Kidney Intragraft Homing ofDe NovoDonor-Specific HLA Antibodies Is an Essential Step of Antibody-Mediated Damage but NotPer SePredictive of Graft Loss
  53. Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury
  54. Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment
  55. Anti-alpha-enolase antibodies in membranous nephropathy: isotype matters
  56. Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal Urine
  57. Human urinary exosome proteome unveils its aerobic respiratory ability
  58. Acquisition of C3d-Binding Activity by De Novo Donor-Specific HLA Antibodies Correlates With Graft Loss in Nonsensitized Pediatric Kidney Recipients
  59. Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms
  60. Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia
  61. Urine proteome analysis in Dent's disease shows high selective changes potentially involved in chronic renal damage
  62. Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants
  63. A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome: Table 1
  64. Copy number variation analysis identifies novel CAKUT candidate genes in children with a solitary functioning kidney
  65. Immunology of membranous nephropathy: from animal models to humans
  66. Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children
  67. Translational Research Methods: Basics of Renal Molecular Biology
  68. Regulatory T cells and minimal change nephropathy: in the midst of a complex network
  69. A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome
  70. Low-dose ofatumumab for rituximab-resistant nephrotic syndrome
  71. Multi-antibody composition in lupus nephritis: Isotype and antigen specificity make the difference
  72. The human urinary exosome as a potential metabolic effector cargo
  73. Stable incorporation of α-smooth muscle actin into stress fibers is dependent on specific tropomyosin isoforms
  74. Widening and Diversifying the Proteome Capture by Combinatorial Peptide Ligand Libraries via Alcian Blue Dye Binding
  75. Renal denervation for severe hypertension in a small child with Turner syndrome: miniaturisation of the procedure and results
  76. Combinatorial Peptide Ligand Library and two dimensional electrophoresis: New frontiers in the study of peritoneal dialysis effluent in pediatric patients
  77. Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial
  78. From hundreds to thousands: Widening the normal human Urinome (1)
  79. Posttransplant Soluble B-Cell Activating Factor Kinetics in Pediatric Recipients of First Kidney Allograft
  80. From hundreds to thousands: Widening the normal human Urinome
  81. Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens
  82. LPS Nephropathy in Mice Is Ameliorated by IL-2 Independently of Regulatory T Cells Activity
  83. 2DE Maps in the Discovery of Human Autoimmune Kidney Diseases: The Case of Membranous Glomerulonephritis
  84. The Latest Advancements in Proteomic Two-dimensional Gel Electrophoresis Analysis Applied to Biological Samples
  85. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens
  86. The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia
  87. Amoxicillin-associated interference in an HPLC–EC assay for urinary fractionated metanephrines: Potential pitfall in pheochromocytoma biochemical diagnosis
  88. Uromodulin: from monogenic to multifactorial diseases: FIGURE 1:
  89. Novel INF2 mutations in an Italian cohort of patients with focal segmental glomerulosclerosis, renal failure and Charcot-Marie-Tooth neuropathy
  90. Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy
  91. Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo: α-Enolase and Annexin AI
  92. DQ molecules are the principal stimulators ofde novodonor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant
  93. Phenotypic Expansion of DGKE-Associated Diseases
  94. Albumin heterogeneity in low-abundance fluids. The case of urine and cerebro-spinal fluid
  95. Oxidized albumin. The long way of a protein of uncertain function
  96. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome
  97. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases
  98. Mutations in DSTYK and Dominant Urinary Tract Malformations
  99. A challenging case of renovascular hypertension
  100. Magnetic resonance urography and laparoscopy in paediatric urology: a case series
  101. Genetic screening in adolescents with steroid-resistant nephrotic syndrome
  102. Circulating Antipodocyte Antibodies in Membranous Nephropathy: New Findings
  103. Combinatorial ligand libraries as a two-dimensional method for proteome analysis
  104. Mutation of the Mg2+TransporterSLC41A1Results in a Nephronophthisis-Like Phenotype
  105. Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders
  106. Lupus nephritis in children and adolescents: results of the Italian Collaborative Study
  107. A prospective observational study of associated anomalies in Hirschsprung’s disease
  108. Constitutional Nephrin Deficiency in Conditionally Immortalized Human Podocytes Induced Epithelial-Mesenchymal Transition, Supported byβ-Catenin/NF-kappa B Activation: A Consequence of Cell Junction Impairment?
  109. Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity
  110. Copy-Number Disorders Are a Common Cause of Congenital Kidney Malformations
  111. Circulating suPAR in Two Cohorts of Primary FSGS
  112. Urinary proteome in a snapshot: normal urine and glomerulonephritis
  113. Intraureteral Injection of NASHA/Dx Gel Under Direct Ureteroscopic Visualization for the Treatment of Primary High-Grade Vesicoureteral Reflux
  114. Oxidized Albumin
  115. PosttransplantDe NovoDonor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection
  116. Regarding Maas's editorial letter on serum suPAR levels
  117. Coexistence of Different Circulating Anti-Podocyte Antibodies in Membranous Nephropathy
  118. Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
  119. Urinary secretion and extracellular aggregation of mutant uromodulin isoforms
  120. Combinatorial peptide ligand libraries for the analysis of low-expression proteins: Validation for normal urine and definition of a first protein MAP
  121. Wolfram Syndrome: New Mutations, Different Phenotype
  122. “Cheek-to-cheek” urinary proteome profiling via combinatorial peptide ligand libraries: A novel, unexpected elution system
  123. Reply
  124. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens
  125. Renal fibrosis and proteomics: Current knowledge and still key open questions for proteomic investigation
  126. Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome
  127. The rediscovery of uromodulin (Tamm–Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease
  128. New insights into membranous glomerulonephritis: from bench to bedside
  129. Oxidative Stress and Galactose-Deficient IgA1 as Markers of Progression in IgA Nephropathy
  130. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome
  131. TRPC6 Mutations in Children with Steroid-Resistant Nephrotic Syndrome and Atypical Phenotype
  132. Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
  133. Analysis of the oxido-redox status of plasma proteins. Technology advances for clinical applications
  134. 'Congenital solitary functioning kidneys: which ones warrant follow-up into adult life?'
  135. Genome-wide association study identifies susceptibility loci for IgA nephropathy
  136. The kidney as a target organ in pharmaceutical research
  137. In vivo characterization of renal auto-antigens involved in human auto-immune diseases: The case of membranous glomerulonephritis
  138. Urinary Proteomics and Drug Discovery in Chronic Kidney Disease: A New Perspective
  139. Protein–protein interaction heterogeneity of plasma apolipoprotein A1 in nephrotic syndrome
  140. Mutations in SOX17 are associated with congenital anomalies of the kidney and the urinary tract
  141. Proteome profile of peritoneal effluents in children on glucose- or icodextrin-based peritoneal dialysis
  142. Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome
  143. Nephrectomy for multicystic dysplastic kidney and renal hypodysplasia in children: where do we stand?
  144. Endocellular polyamine availability modulates epithelial-to-mesenchymal transition and unfolded protein response in MDCK cells
  145. 2D-electrophoresis and the urine proteome map: Where do we stand?
  146. A Novel WT1 Gene Mutation in a Three-Generation Family with Progressive Isolated Focal Segmental Glomerulosclerosis
  147. Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2
  148. Late onset of pANCA renal and pulmonary vasculitis in a girl affected by undifferentiated connective tissue disease
  149. Familial forms of nephrotic syndrome
  150. Five cases of severe vesico-ureteric reflux in a family with an X-linked compatible trait
  151. AHI1 is required for photoreceptor outer segment development and is a modifier for retinal degeneration in nephronophthisis
  152. NovelTMEM67mutations and genotype-phenotype correlates in meckelin-related ciliopathies
  153. A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples
  154. Two cases of swine H1N1 influenza presenting with hematuria as prodrome
  155. The oxido-redox potential of albumin
  156. ExpandingCEP290mutational spectrum in ciliopathies
  157. Locus heterogeneity of Dent’s disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations
  158. Renal outcome in patients with congenital anomalies of the kidney and urinary tract
  159. 2nd Combined Working Group and Management Committee Meeting of Urine and Kidney Proteomics COST Action 29-30 March 2009, Nafplio, Greece
  160. Combinatorial peptide ligand libraries for urine proteome analysis: Investigation of different elution systems
  161. A Recessive Gene for Primary Vesicoureteral Reflux Maps to Chromosome 12p11-q13
  162. Posttransplant Proteinuria Associated With Everolimus
  163. Clinical Features and Long-Term Outcome of Nephrotic Syndrome Associated with Heterozygous NPHS1 and NPHS2 Mutations
  164. The impact of eNOS, MTR and MTHFR polymorphisms on renal graft survival in children and young adults
  165. Hirschsprung Disease and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
  166. MKS3/TMEM67mutations are a major cause of COACH Syndrome, a Joubert Syndrome related disorder with liver involvement
  167. Immature Renal Structures Associated With a Novel UMOD Sequence Variant
  168. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)
  169. New iodo-acetamido cyanines for labeling cysteine thiol residues. A strategy for evaluating plasma proteins and their oxido-redox status
  170. Recurrent lymphomatoid papulosis associated with nephrotic syndrome. An occurrence of uncertain origin
  171. Genetic risk factors in typical haemolytic uraemic syndrome
  172. Post-transplant proteinuria associated with everolimus: Definition of main features with proteomics
  173. Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives
  174. Proteins and protein fragments in nephrotic syndrome: Clusters, specificity and mechanisms
  175. Collapsing glomerulopathy associated with inherited mitochondrial injury
  176. Glomerulocystic kidney disease in hypomelanosis of Ito
  177. RPGRIP1L mutations are mainly associated with the cerebello-renal phenotype of Joubert syndrome-related disorders
  178. Association of the macrophage migration inhibitory factor −173*C allele with childhood nephrotic syndrome
  179. Determination of the oxido-redox status of plasma albumin in hemodialysis patients
  180. SIX2 and BMP4 Mutations Associate With Anomalous Kidney Development
  181. High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma
  182. Proteomics of Plasma and Urine in Primary Nephrotic Syndrome in Children
  183. Erratum to: Genetic approaches to human renal agenesis/hypoplasia and dysplasia
  184. Genetic approaches to human renal agenesis/hypoplasia and dysplasia
  185. COQ2 Nephropathy: A Newly Described Inherited Mitochondriopathy with Primary Renal Involvement
  186. Protracted remission of proteinuria after combined therapy with plasmapheresis and anti-CD20 antibodies/cyclophosphamide in a child with oligoclonal IgM and glomerulosclerosis
  187. Teaching molecular genetics: chapter 4—positional cloning of genetic disorders
  188. CEP290 Mutations Are Frequently Identified in the Oculo-Renal Form of Joubert Syndrome–Related Disorders
  189. Lack of cardiac anomalies in children with NPHS2 mutations
  190. Localization of a Gene for Nonsyndromic Renal Hypodysplasia to Chromosome 1p32-33
  191. Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin
  193. Comparative study of thermal stability of healthy and focal segmental glomerulosclerosis plasma albumin
  194. Recurrent Nephrotic Syndrome in Homozygous Truncating NPHS2 Mutation Is Not Due to Anti-Podocin Antibodies
  195. Podocin-Related Mechanisms in Posttransplantation Recurrence of Focal Segmental Glomerulsclerosis
  196. Recurrent autosomal-dominant focal segmental glomerulosclerosis
  197. Characterization of oxidation end product of plasma albumin ‘in vivo’
  198. Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases
  199. Nephronophthisis type 1 deletion syndrome with neurological symptoms: Prevalence and significance of the association
  200. WT1 mutations in nephrotic syndrome revisited. High prevalence in young girls, associations and renal phenotypes
  201. Repetitive Fragmentation Products of Albumin and α1-Antitrypsin in Glomerular Diseases Associated with Nephrotic Syndrome
  202. Prevalence of Mutations in Renal Developmental Genes in Children with Renal Hypodysplasia: Results of the ESCAPE Study
  203. Posttransplant Recurrence of Proteinuria in a Case of Focal Segmental Glomerulosclerosis Associated with WT1 Mutation
  204. Defective Intracellular Trafficking of Uromodulin Mutant Isoforms
  205. Glomerular clusterin is associated with PKC-α/β regulation and good outcome of membranous glomerulonephritis in humans
  206. Phenotypic and genetic heterogeneity in Dent's disease—the results of an Italian collaborative study
  207. Transitions of serum albumin in patients with glomerulosclerosis ‘in vivo’ characterization by electrophoretic titration curves
  208. Stop codon at arginine 586 is the prevalent nephronopthisis type 1 mutation in Italy
  209. IgA Nephropathy: The Presence of Familial Disease Does Not Confer an Increased Risk for Progression
  210. Rare Functional Variants of Podocin (NPHS2) Promoter in Patients With Nephrotic Syndrome
  211. Discordant evolution of nephrotic syndrome in mono- and dizygotic twins
  212. The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait
  213. Recurrent Focal Glomerulosclerosis
  214. Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome
  215. Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes
  216. New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis
  217. Familial Vesicoureteral Reflux: Testing Replication of Linkage in Seven New Multigenerational Kindreds
  218. Uromodulin storage diseases: Clinical aspects and mechanisms
  219. Hyponatremic-hypertensive syndrome with extensive and reversible renal defects
  220. Heterozygous NPHS1 or NPHS2 mutations in responsive nephrotic syndrome and the multifactorial origin of proteinuria
  221. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study
  222. Glomerular albumin permeability as anin vitromodel for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence
  223. The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis
  224. Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis
  225. Infantile steroid-resistant nephrotic syndrome associated with double homozygous mutations of podocin
  226. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy
  227. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics
  228. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood
  229. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin
  230. Soft immobilized pH gradient gels in proteome analysis: A follow-up
  231. Broadening the Spectrum of Diseases Related to Podocin Mutations
  232. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome
  233. Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis
  234. Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)
  235. Depletion of clusterin in renal diseases causing nephrotic syndrome
  236. Glomerulocystic kidney disease in a family
  237. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders
  238. Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli
  239. Two-dimensional maps in soft immobilized pH gradient gels: A new approach to the proteome of the Third Millennium
  240. Expression of Nuclear Transcription Factor PAX2 in Renal Biopsies of Juvenile Nephronophthisis
  241. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene
  242. Inhibition of renal permeability towards albumin: A new function of apolipoproteins with possible pathogenetic relevance in focal glomerulosclerosis
  243. Permeability plasma factors in nephrotic syndrome: more than one factor, more than one inhibitor
  244. Localisation of the gene responsible for Fechtner syndrome in a region <600 Kb on 22q11–q13
  245. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes
  246. Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter: POSSIBLE INVOLVEMENT OF Ku ANTIGEN
  247. A DNA element in the α1 type III collagen promoter mediates a stimulatory response by angiotensin II
  248. Characterization of a DNA binding site that mediates the stimulatory effect of cyclosporin‐A on type III collagen expression in renal cells
  249. Clinical and molecular heterogeneity of juvenile nephronophthisis in Italy: Insights from molecular screening
  250. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome
  251. Identification of a New Locus for Medullary Cystic Disease, on Chromosome 16p12
  252. N-(4-hydroxyphenyl)retinamide inhibitscystogenesis by polycystic epithelial cell lines in vitro
  254. Renal-retinal syndromes: Association of retinal anomalies and recessive nephronophthisis in patients with homozygous deletion of the NPH1 locus
  255. Transforming growth factor β blocks cystogenesis by MDCK epithelium in vitro by enhancing the paracellular flux: Implication of collagen V
  256. Autosomal dominant medullary cystic disease: a disorder with variable clinical pictures and exclusion of linkage with the NPH1 locus
  257. Activation of COL3A1 Promoter Activity by Cyclosporine
  258. Resolution of fibronectin and other uncharacterized proteins by two-dimensional polyacrylamide electrophoresis with thiourea
  259. Micro-injection of recombinant lysyl oxidase blocks oncogenic p21-Ha-Ras and progesterone effects on Xenopus laevis oocyte maturation
  260. alpha1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications
  261. Molecular genetic identification of families with juvenile nephronophthisis type 1: Rate of progression to renal failure
  262. Negative Staining of Proteins in Polyacrylamide Gels with Methyl Trichloroacetate
  263. A new biallelic DNA polymorphism of the human COL5A1 gene
  264. Activation of the intracellular glutathione system by oxydative stress during cardiopulmonary bypass and myocardial perfusion
  265. Urinary proteins in vesicoureteric reflux: when the same thinking leads to different conclusions
  266. Purification of alpha-1-antitrypsin monomer by preparative electrophoresis.
  268. Selective enhancement by cyclosporin A of collagen expression by mesangial cells ‘in culture’
  269. Protracted high-dose interferon gamma therapy for chronic experimental nephropathy
  270. Extracellular matrix formation by epithelial cells from human polycystic kidney cysts in culture
  271. Normal levels of urinary brush border antigens and other tubular markers in children
  272. Are the nail-patella syndrome and the autosomal Goltz-like syndrome the phenotypic expressions of different alleles at the COL5A1 locus?
  273. Progression of Chronic Adriamycin Nephropathy in Leukopenic Rats
  274. Rat model of perchloroethylene-induced renal dysfunctions
  275. Mapping of the human COL5A1 gene to chromosome 9q34.3
  276. Multiple mechanisms for doxorubicin cytotoxicity on glomerular epithelial cells ‘in vitro’
  277. Urinary excretion of brush border antigens and other proteins in children with vesico-ureteric reflux
  278. Puromycin aminonucleoside metabolism by glomeruli and glomerular epithelial cells in vitro
  279. Purification and partial characterization of a new 85 KDa amyloidosis-related protein in chronic hemodialysis
  280. Interaction between cationic dyes and erythrocyte membranes in minimal change nephropathy: an electrophoretic approach
  281. Jean Jaures, la France, l'Allemagne et la Deuxieme Internationale a la veille de la Premiere Guerre mondiale
  282. Purification of Proteinase-Free Collagenase from Commercial Batches of the Enzyme
  283. Hypertension and Renal Selectivity Properties in Diabetic Microalbuminuria
  284. Low-Protein Diet and Xanthine-Metabolising Enzymes in Adriamycin Nephrosis
  285. Urinary excretion of brush-border antigen and plasma proteins in early stages of diabetic nephropathy
  286. Analysis of albumin charge by direct immunofixation in ultrathin gels
  287. Tubular Epithelium Culture from Nephronophthisis-Affected Kidneys: A New Approach to Molecular Disorders of Tubular Cells
  288. Peroxidative damage of the erythrocyte membrane in children with nephrotic syndrome
  289. Preparative High Performance Chromatography of a Major Browning Compound Derived from Lysine and Glucose
  290. Reaction of 2-amino-2-deoxy-d-glucose and lysine: Isolation and characterization of 2,5-bis(tetrahydroxybutyl)pyrazine
  291. Hydrophobic interaction of alcian blue with soluble and erythrocyte membrane proteins
  292. Spectrophotometric determination of browning products of glycation of protein amino groups based on their reactivity with nitro blue tetrazolium salts
  293. Purification of intact concanavalin A in tetramers by isoelectric focusing
  294. Characterisation of the phenylhydrazone derivatives of “glycated albumin” purified from diabetic sera
  295. Fractionation of human serum albumin isoforms with chromatofocusing
  296. Isoelectric focusing in low-denaturing media: Visualization in renal disease of variation of the isoelectric point of albumin not related to a remarkable conformational variation
  297. Separation of the 9-anthryldiazomethane derivatives of fatty acids by high-performance liquid chromatography on a Fatty Acid Analysis Column®
  298. Spectrophotometric determination of advanced products of non-enzymatic glycosylation of lysine by means of their reaction with diazonium salts
  299. Reaction of human serum albumin with aldoses
  300. Reaction of lysine with aldoses
  301. Highly selective one-step chromatography of serum and urinary albumin on immobilized Cibacron Blue F3GA. Studies on normal and glycosyl albumin
  302. Silver stain of proteins in ultra-thin gels containing carrier ampholytes — detection of glycosyl albumin with anionic and cationic charge in serums of diabetic patients
  303. A modification of the 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) method for the determination of the sulphhydryl content of human serum albumin
  304. Determination of a glycosyl subunit of human serum albumin by concanavalin A-Sepharose